Merck KGaA

Merck KGaA has made an organizational change in the Merck Generics Group (MGG), naming J. Melville Engle to the position of MGG regional director, North America. Mr. Engle will retain his current position of president and chief executive officer of Napa, CA-based DEY, L.P., a subsidiary of Merck.

Mr. Engle will oversee Genpharm Inc., one of Canada’s largest generic drug companies, as well as Genpharm L.P., MGG’s new U.S. generics business. He joined DEY in January 2002 and was named president and chief executive officer in October 2002. Prior to that he served as chairman, president and chief executive officer of Anika Therapeutics, and president and chief executive officer of U.S. Medical Products.